Dimensional Fund Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.4M Buy
35,835
+4,261
+13% +$1.41M ﹤0.01% 2254
2026
Q2
$10.6M Buy
31,574
+413
+1% +$131K ﹤0.01% 2278
2026
Q1
$10M Buy
31,161
+7,618
+32% +$2.36M ﹤0.01% 2258
2025
Q4
$6.94M Sell
23,543
-13,871
-37% -$2.58M ﹤0.01% 2415
2025
Q3
$1.98M Buy
+37,414
New +$1.81M ﹤0.01% 2766
2025
Q1
– Sell
-4,544
Closed -$350K – 3348
2024
Q4
$350K Sell
4,544
-545
-11% -$39.4K ﹤0.01% 3086
2024
Q3
$293K Sell
5,089
-1,799
-26% -$97.2K ﹤0.01% 3115
2024
Q2
$284K Sell
6,888
-8,152
-54% -$385K ﹤0.01% 3113
2024
Q1
$918K Buy
15,040
+1,330
+10% +$59.7K ﹤0.01% 2938
2023
Q4
$305K Buy
13,710
+12,302
+874% +$222K ﹤0.01% 3131
2023
Q3
$36.1K Hold
1,408
– – ﹤0.01% 3404
2023
Q2
$24.3K Sell
1,408
-15,102
-91% -$231K ﹤0.01% 3445
2023
Q1
$200K Buy
+16,510
New +$697K ﹤0.01% 3200
2022
Q3
$93K Buy
+2,736
New +$136K ﹤0.01% 3349

Other funds holding PRAX

Dimensional Fund Advisors's PRAX Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Praxis Precision Medicines (PRAX) stake by 13% in Q3 2026, buying an estimated $1.41M and bringing the position to 35,835 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2254.

Dimensional Fund Advisors first reported a position in PRAX in Q3 2022 and has held it in 14 quarters since. The position peaked at $10.6M in Q2 2026. 86 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Dimensional Fund Advisors held 35,835 shares of Praxis Precision Medicines worth $10.4M as of Q3 2026.
  • Dimensional Fund Advisors bought 4,261 Praxis Precision Medicines shares in Q3 2026, an estimated $1.41M.
  • Praxis Precision Medicines made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2254 holding.
  • Dimensional Fund Advisors first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 14 quarters since.
  • Dimensional Fund Advisors's Praxis Precision Medicines position peaked at $10.6M in Q2 2026.
  • 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.